Discusses research being done on the effect of hormonal theraphy with leuprorelin on spinal and bulbar muscular atrophy phenotypes in a mouse model of the disease. Reference to a study by M. Katsuno et al published in the May 18, 2003 issue of 'Nature Medicine.'